Synthesis of the first α-fluoro-phosphotyrosyl mimetic

Synthetic Communications

Volumn 34, Issue 21, 2004, Pages 3883-3889

  Shi, Zhen Dan ^a   Liu, Hongpeng ^b   Zhang, Manchao ^b   Yang, Dajun ^b   Burke Jr , Terrence R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chiral induction; Enantioselective; Fluorination; Phosphotyrosyl mimetic

Indexed keywords

2 FLUORO 4 [[BIS(1,1 DIMETHYLETHOXY)PHOSPHINYL]METHYL]BENZENEPROPANOIC ACID; 4 PHENYL 2 OXAZOLIDINONE; BENZENE DERIVATIVE; FLUORINE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PEPTIDE DERIVATIVE; PHOSPHOTYROSINE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; FLUORINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SUBSTITUTION REACTION;

EID: 7644221986     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-200034770     Document Type: Article

References (15)

1. Welch, J.T. Advances in the preparation of biologically active organofluorine compounds. Tetrahedron 1987, 43, 3123-3197.
2. Burke, T.R., Jr.; Yao, Z.-J.; Liu, D.-G.; Voigt, J.; Gao, Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers 2001, 60, 32-44.
3. Burke, T.R.; Smyth, M.S.; Nomizu, M.; Otaka, A.; Roller, P.P. Preparation of fluoro-4-(phosphonomethyl)-D,L-phenylalanine and hydroxy-4-(phosphonomethyl) -D,L-phenylalanine suitably protected for solid-phase synthesis of p Peptides containing hydrolytically stable analogs of O-phosphotyrosine. J. Org. Chem. 1993, 58, 1336-1340.
4. Burke, T.R.; Liu, D.G.; Gao, Y. Use of a Heck reaction for the synthesis of a new alpha-azido phosphotyrosyl mimetic suitably protected for peptide synthesis. J. Org. Chem. 2000, 65, 6288-6291.
5. Marseigne, I.; Roques, B.P. Synthesis of new amino acids mimicking sulfated and phosphorylated tyrosine residues. J. Org. Chem. 1988, 55, 3621-3624.
6. Burke, T.R., Jr.; Russ, P.; Lim, B. Preparation of 4-[bis(tert-butyl) phosphonomethyl]-N-Fmoc-DL-phenylalanine; a hydrolytically stable analogue of O-phosphotyrosine potentially suitable for peptide synthesis. Synthesis 1991, 11, 1019-1020.
7. Fritz-Langhals, E.; Schutz, G. Simple synthesis of optically active 2-fluoroproprionic acid analogues of high enantiomeric purity. Tetrahedron Lett. 1993, 34, 293-296.
8. Evans, D.A.; Britton, T.C.; Ellman, J.A.; Dorow, R.L. The asymmetric synthesis of α-amino acids. Electrophilic azidation of chiral imide enolates, a practical approach to the synthesis of (R)- and (S)-α-azido carboxylic acids. J. Am. Chem. Soc. 1990, 112, 4011-4030.
9. Davis, F.A.; Han, W. Diastereoselective fluorination of chiral imide enolates using N-fluoro-O-benzenedisulfonimide (NFOBS). Tetrahedron Lett. 1992, 33, 1153-1156.
10. Available from Sigma Aldrich Chemical Corp., Milwaukee, WI, USA.
11. Gao, Y.; Wei, C.-Q.; Burke, T.R., Jr. Olefin metathesis in the design and synthesis of a globally constrained Grb2 SH2 domain inhibitor. Org. Lett. 2001, 3, 1617-1620.
12. Furet, P.; Gay, B.; Caravatti, G.; GarciaEcheverria, C.; Rahuel, J.; Schoepfer, J.; Fretz, H. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain. J. Med. Chem. 1998, 41, 3442-3449.
13. Yao, Z.J.; King, C.R.; Cao, T.; Kelley, J.; Milne, G.W.A.; Voigt, J.H.; Burke, T.R. Potent inhibition of Grb2 SH2 domain binding by nonphosphate- containing ligands. J. Med. Chem. 1999, 42, 25-35.
14. Carpino, L.A.; Imazumi, H.; Foxman, B.M.; Vela, M.J.; Henklein, P.; El-Faham, A.; Klose, J.; Bienert, M. Comparison of the effects of 5- and 6-HOAt on model peptide coupling reactions relative to the cases for the 4- and 7-isomers. Org. Lett. 2000, 2, 2253.
15. Liu, D.-G.; Yao, Z.-J.; Gao, Y.; Burke, T.R., Jr. Large scale preparation of cell permeable, non-phosphate-containing Grb2 SH2 domain inhibitors. Org. Prep. Proc. Int. 2000, 32, 197.